Cargando…
Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer
Prostate cancer (PCa) is the second most frequent cancer in men worldwide. NF-κB seems to play a key role in cell survival, proliferation and invasion, sustaining the heterogeneous multifocal nature of PCa. In recent years, the Hedgehog (Hh) signaling pathway has attracted attention as a therapeutic...
Autores principales: | Vecchiotti, Davide, Verzella, Daniela, Di Vito Nolfi, Mauro, D’Andrea, Daniel, Flati, Irene, Di Francesco, Barbara, Cornice, Jessica, Alesse, Edoardo, Capece, Daria, Zazzeroni, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266159/ https://www.ncbi.nlm.nih.gov/pubmed/35805202 http://dx.doi.org/10.3390/cells11132118 |
Ejemplares similares
-
NF-κB: A Druggable Target in Acute Myeloid Leukemia
por: Di Francesco, Barbara, et al.
Publicado: (2022) -
EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?
por: Di Vito Nolfi, Mauro, et al.
Publicado: (2022) -
Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression
por: Flati, Irene, et al.
Publicado: (2023) -
The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target
por: Verzella, Daniela, et al.
Publicado: (2022) -
Ultrasound-Based Method for the Identification of Novel MicroRNA Biomarkers in Prostate Cancer
por: Cornice, Jessica, et al.
Publicado: (2021)